banner
Raf inhibitor Regorafenib monohydrate, Purity ≥98%
Inquiry

Cat. No.: X23-10-ZQ189

Raf inhibitor Regorafenib monohydrate, Purity ≥98%

Synonym: 1019206-88-2; Regorafenib monohydrate; Regorafenib hydrate; Regorafenib (monohydrate); Regorafenib hydrate [JAN]; BAY 73-4506 monohydrate; 4-[4-[[[[4-Chloro-3-(trifluoromethyl)phenyl]amino]carbonyl]amino]-3-fluorophenoxy]-N-methyl-2-pyridinecarboxamide hydrate; Raf inhibitor

  • MDL: MFCD17170366
  • CAS Number: 1019206-88-2
  • Compound CID: 24768591
img
Product Size
50 mg; 100 mg; 200 mg; 500 mg
Price
Datasheet
MSDS
Properties
Description
Regorafenib monohydrate, soluble in DMSO and ethanol, blocks a MAPK/ERK signaling pathway.
Molecular Weight
500.83
Molecular Formula
C21H17ClF4N4O4
Form
Lyophilized powder
Purity
≥98%
Solubility
DMSO: 93 mg/mL (185.68 mM); Ethanol: <1 mg/mL
Identity
Confirmed by NMR/HPLC/MS.
Applications
Regorafenib monohydrate can be studied for its effects on targeting multiple kinases involved in tumor growth and angiogenesis.
Publications
Publications (0)

Publications

×
Publications

Thank you for choosing our products for your research. By sharing your publications or experimental feedback, you provide invaluable insights that help fellow scientists accelerate their discoveries. Your contribution also drives our commitment to continuous product optimization.

As a token of our appreciation, verified submissions will receive an exclusive discount code for your next order.

*Submitted research data and images may be featured on our product pages. We strictly protect your personal privacy; no sensitive contact information will ever be disclosed.

  • You can upload up to 5 images or ZIP files, and the size of a single file may not exceed 5MB.
Related Products
Quick Links

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.
0